Study overview
Overview
- Study title
- Economic Burden of Tuberculosis in India
- Participants enrolled
- 1,482
- Lead institute
- George Institute for Global Health
- Principal investigator (PI)
- Susmita Chatterjee (George Institute for Global Health)
- Principal investigator profile
- Open profile
- Study design
- Prospective
- Location
- Assam, Maharashtra, Tamil Nadu & West Bengal
- Single / multiple sites
- Multiple Sites
- Key highlights
- This cohort study assessed the economic burden of tuberculosis treatment among 1,482 drug-susceptible and multidrug-resistant TB patients. Participants were recruited in 2019 from public health facilities and followed through different treatment phases. The study evaluated catastrophic costs and the financial impact of TB treatment across diverse populations, including slum dwellers and tea garden workers.
- Reference paper 1
- https://doi.org/10.1371/journal.pgph.0003078
Insights & criteria
Insights
- Exclusion criteria
- Drug-resistant TB patients
- Socio‑demographic / economic
- Urban/ Rural
- Recruitment and timeline
- 2019-2023
- Follow‑up
- 5-6 Months of treatment
1 year post treatment - Keywords
- Infectious Diseases
Details
Details
- Age group
- ≥18 years
- Gender
- Men & Women
- Scope
- National
- Category
- Disease-Specific Cohort